When Rocket Lab Corp (RKLB) reports its fourth-quarter earnings after the bell on Thursday, it's not just another earnings call. It's a check-in on one of the most interesting stories in the new space race. The company, often mentioned in the same breath as SpaceX (private), has been on a roll, consistently beating revenue expectations. The question now is: can it keep the momentum going?
Analysts are expecting the company to post revenue of $178.07 million, according to market data. That's a healthy jump from the $132.39 million it reported in the same quarter last year. If it hits that number, it would be the company's third consecutive record-breaking quarter, topping the $155.1 million it posted in Q3. More impressively, it would mark the seventh straight quarter where Rocket Lab has beaten Wall Street's revenue estimates.
On the bottom line, the story is still about investment and growth. Analysts are forecasting a loss of nine cents per share, which is a slight improvement from the ten-cent loss per share a year ago. The company's own guidance has been pointing toward revenue in the range of $170 million to $180 million, so it's set up to meet or exceed expectations.
What Are the Analysts Saying?
The analyst community has been busy reshuffling their views on Rocket Lab lately, and the opinions are all over the map. It's a classic case of seeing the glass as either half-full of rocket fuel or half-empty.
On the bullish side, Morgan Stanley (MS) made a significant move, upgrading the stock from Equal-Weight to Overweight and boosting its price target from $67 to $105. Bank of America (BAC) Securities maintained its Buy rating and nearly doubled its price target from $60 to $120. Goldman Sachs (GS) is playing it cooler, maintaining a Neutral rating but still raising its target from $47 to $69.
Not everyone is on board, however. KeyBanc Capital Markets downgraded Rocket Lab from Overweight to Sector Weight, essentially taking a step back and removing its price target. It's a reminder that even in a hot sector, not every analyst is convinced the trajectory is sustainable.
Beyond the Numbers: The Launch Pad is Busy
The financials are one thing, but for a rocket company, the real story is written on the launch pad. Management's commentary will likely focus on two things: contracts and countdowns.
Rocket Lab bagged 17 launch contracts for its Electron rocket in the third quarter and hinted it would break its annual launch record in Q4. The earnings report will show if they succeeded and reveal how many new contracts were signed amidst all that activity.
The company has already started 2026 with a bang, completing its 80th and 81st launches just eight days apart in late January. "Two launches in eight days is a strong start to the year that speaks volumes about the demand for Electron and the excellence and dedication of the Rocket Lab team," CEO Peter Beck said after the second launch. He's predicting "an even busier launch year in 2026," so investors will be listening for any guidance on the total launch cadence for the year.
There's also a potentially huge government contract in the works. Rocket Lab is part of the Pentagon's Golden Dome initiative under a program called SHIELD. The earnings call could provide more details on the size and scope of this opportunity, which represents a significant vote of confidence from the U.S. defense establishment.
It hasn't all been smooth sailing, of course. The company will likely address setbacks, like the HASTE launch that was scrubbed on Wednesday. How a company handles these inevitable hiccups is often as telling as celebrating the successes.
The Bigger Picture: ETFs and the SpaceX Shadow
Rocket Lab's performance doesn't exist in a vacuum. It's a bellwether for the entire public space investment theme. The stock is the second-largest holding in the Ark Space & Defense Innovation ETF (ARKX), making up 7.25% of the fund. It's also the sixth-largest holding in the Procure Space ETF (UFO), with a 4.58% weighting. A strong report from Rocket Lab could lift these entire ETFs.
Then there's the elephant not yet in the room: SpaceX. The increased chatter about a potential SpaceX IPO in 2026 is a double-edged sword for Rocket Lab. On one hand, it could draw massive attention and capital to the sector, which might benefit all players. On the other hand, it creates a direct, gargantuan competitor for public investor dollars. Analysts will almost certainly ask Rocket Lab's management about this. Their answers could touch on whether they see their valuation as undervalued compared to the SpaceX juggernaut and how a pure-play public launch competitor might change the game.
Where's the Stock?
After a monster run in 2025 where shares gained over 200%, Rocket Lab stock has taken a breather in 2026, down about 7.6% year-to-date. It closed Wednesday at $70.20, sitting comfortably above its 52-week low of $14.72 but well off its high of $99.58. The stock is consolidating, and this earnings report could be the catalyst that decides its next major move—up toward those previous highs or into a deeper pullback.
So, when you tune in Thursday, don't just listen for whether they beat or miss by a penny. Listen for the contract pipeline, the launch tempo, and the confidence (or caution) in the voice of management. In the rocket business, the future is always the most important payload.
